Joyance Partners

Founded in 2012, Joyance Partners is a venture capital firm based in San Francisco. It invests in early-stage companies focused on emerging science and bio-based technologies that empower individuals' health and well-being within two years, as well as startups whose products increase joy, fulfillment, and independence for customers.

Omar Al-Busaidi

Investment Partner and Venture Partner

Yang Chen

Investor

Sonia Dewar

Investment Partner

Toshi Eguchi

Managing Director, Joyance Asia

James Louderback

Venture Partner

Hidenari Nakayama Ph.D

Venture Partner, Joyance Partners

Seth Rosenblatt

Venture Partner

Nobuhiro Takanuma

Partner, Joyance Partners

Neha Tanna MD

Venture Partner

Past deals in Mental Health

Millie

Series A in 2025
Millie is a maternity care platform and clinic that aims to improve clinical outcomes and provide a seamless experience for expectant and new parents, built by mothers and providers with firsthand experience, offering a new type of maternity clinic that supports remote health monitoring, home postpartum visits, and parenthood guidance through an app, including one-to-one doula coaching, and combining clinical care with practical support during and after the maternal phase to simplify access to care and enhance the overall experience for families.

Kyan Health

Series A in 2024
Kyan Health is a Swiss digital health company specializing in personalized, evidence-based mental wellbeing solutions for employees and their families. It offers end-to-end support services, including employee engagement, self-improvement resources, coaching, and counseling.

Wave Life

Seed Round in 2023
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.

GrayMatters Health

Series A in 2022
GrayMatters Health develops digital therapeutics for mental health and related neurological disorders, grounded in self-regulation of brain processes and brain biomarkers. The technology aims to deliver self-neuromodulation treatments that enhance efficacy, safety, and accessibility, enabling healthcare professionals to use neuroscience-based digital interventions within clinical practice and to complement conventional care with non-pharmacological options.

GrayMatters Health

Seed Round in 2020
GrayMatters Health develops digital therapeutics for mental health and related neurological disorders, grounded in self-regulation of brain processes and brain biomarkers. The technology aims to deliver self-neuromodulation treatments that enhance efficacy, safety, and accessibility, enabling healthcare professionals to use neuroscience-based digital interventions within clinical practice and to complement conventional care with non-pharmacological options.

Limbic

Convertible Note in 2019
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

Lucid Care

Pre Seed Round in 2019
Lucid Care, established in 2018 and headquartered in Palo Alto, California, specializes in developing Virtual Reality (VR) tools to enhance the treatment of Substance Use Disorders (SUD) and mental health conditions. The company provides a VR platform to treatment centers, which increases patient engagement and retention by significantly reducing anxiety and cravings, often within a single session. This platform enables patients to cultivate positive daily habits that support their ongoing treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.